A class action lawsuit is a legal proceeding initiated by a group of people. These individuals share common circumstances, damages, or injuries caused by the same product, action, or company. For example, if a pharmaceutical company releases a harmful drug, all affected patients could join a class action suit against the firm.
The unified claim of a class action lawsuit allows for efficient court proceedings and can ensure fair compensation distribution. Now, let us take a look at three different class action lawsuits that you should know about if you are a resident of New York City.
1. Tylenol Autism Lawsuits
Although women have been advised by healthcare providers for decades to use the acetaminophen-based drug Tylenol to relieve pain during pregnancy, it has now been discovered that acetaminophen is not as safe as it was believed.
A number of studies have linked Tylenol and other acetaminophen-based drugs to the development of ADHD and autism in children.
So, affected parents are now filing lawsuits against companies that sold Tylenol, such as the retailer Walmart, to pursue compensation for things like medical bills and the lost wages they incurred due to managing their children’s conditions.
The U.S. District Judge Denise Cote, for the Southern District of New York, has been presiding over the lawsuits regarding Tylenol.
Seeing as more than 100 plaintiffs have used the same evidence to file complaints against a specific group of defendants, the judge has attempted to simplify the litigation process by consolidating the claims into multidistrict litigation.
2. EzriCare Artificial Tears Lawsuits
EzriCare Artificial Tears, an over-the-counter eye drop product, has been recalled by Global Pharma Healthcare due to findings that it could lead to severe infections.
The outbreak of infections in users of the product began to be recorded in May 2022. The bacterial outbreaks first happened in New York State, Florida, Connecticut, Nevada, Utah, California, New Jersey, Wisconsin, Colorado, Texas, Washington State, and New Mexico.
People who have been harmed by the product, and people whose loved ones died from an infection or other health issue related to EzriCare Artificial Tears are now filing lawsuits to seek compensation.
3. Bard Implanted Port Catheter Lawsuits
New York residents and residents throughout the U.S. should also be aware of the recent news about defective Bard port catheters.
Numerous plaintiffs are filing lawsuits against Bard Access Systems, claiming that the Bard device, which is implanted to enable easier access for administering intravenous substances, contains design flaws that lead it to deteriorate.
In turn, that defect has resulted in patients suffering infections, blood clots, and life-threatening injuries. Affected people are seeking compensation for things like lost wages, medical bills, and pain and suffering.
Where to Learn More and Stay Up to Date with Class Action Lawsuits
It is definitely a good idea to stay up to date with class action lawsuits that are currently happening, both in New York and throughout the country. By staying informed, you can learn about defective or harmful products that are on the market or have been withdrawn from sale. If you use one of those products, you can ensure you stop using it. You can also inform any loved ones who you know use the products.
Furthermore, if you or a loved one develop a health condition that has been linked to a certain defective or harmful product, you can join a class action lawsuit to pursue compensation.
There are a number of legal magazines and online platforms where you can find out about the latest class-action lawsuits and mass tort cases. Lawsuit Legal News is one of the best online resources for up-to-date and detailed information.
Summing Up
Staying informed about emerging class-action lawsuits, such as those involving Tylenol, EzriCare, and Bard Implants, enables residents of New York and other regions to ensure their safety. Furthermore, by remaining up-to-date with the latest cases, potential victims can seek justified compensation when harmed by defective or deleterious products.
